VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | 0.0% | 212 | +21.8% | 0.00% | 0.0% |
| Q2 2023 | $1 | -75.0% | 174 | -67.8% | 0.00% | -66.7% |
| Q1 2023 | $4 | 0.0% | 541 | +1.7% | 0.00% | +50.0% |
| Q4 2022 | $4 | -99.9% | 532 | +90.7% | 0.00% | -33.3% |
| Q3 2022 | $3,000 | 0.0% | 279 | -2.4% | 0.00% | +50.0% |
| Q2 2022 | $3,000 | 0.0% | 286 | -4.7% | 0.00% | 0.0% |
| Q1 2022 | $3,000 | +200.0% | 300 | +294.7% | 0.00% | +100.0% |
| Q4 2021 | $1,000 | – | 76 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |